Arkolith/Insider Trading/SELB/Form 4

Kishimoto Takashi Kei

Chief Scientific OfficerSELECTA BIOSCIENCES INC (SELB) · full profile →Form 4 · filed Jan 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$11K
Net Open-Market Flow
-$11K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 5, 2023Sell(S)3K$1.13$4K364K
Jan 5, 2023Sell(S)20$1.11$22364K
Jan 4, 2023Sell(S)11$1.15$13368K
Jan 4, 2023Sell(S)6K$1.13$7K368K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001453687-23-000033) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML